Fig. 9From: HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4+ T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trialChanges from baseline of CD4+ T-cell number in vaccinees and placebos non compliant to therapy. Baseline values (left panel) and changes from baseline after immunization (right panel) of CD4+ T-cell counts in vaccinees (n = 18) and placebos (n = 5). Data are presented as box plots. Wilcoxon signed rank sum test for paired data and Wilcoxon–Mann–Whitney test were used for the analyses. p values assess the changes from baseline within and between treatment groupsBack to article page